Lilly announces new study data on Inluriyo in metastatic breast cancer
The five-year survival rate for metastatic breast cancer is 30%
- News
- Research
- Sales
- Regulatory
- Healthcare
- Marketing
Lilly announces new study data on Inluriyo in metastatic breast cancer
The five-year survival rate for metastatic breast cancer is 30%
UK and US agree on landmark pharma pricing tariff deal
US tariffs on UK-produced pharmaceuticals will remain at zero for three years
AstraZeneca’s Enhertu combination approved by FDA for HER2-positive breast cancer
Around one in five breast cancer cases are HER2-positive
Lilly announces plans for $6bn US manufacture facility
The site is the third of four new US sites that Lilly has announced
PMLiVE’s T40 2025 – results announced!
Find out which agencies came top and which agencies are among the big climbers in this year’s list
Latest content
Scaling AI in healthcare communications: from pilots to living systems
By Andreas Reinbolz and Thomas Nisters
Read More
Launch differently: how unforgettable brands break through
By Whitney Morley and Jo Crouch
Read More
Intelligence
The trust crisis: how pharma must evolve to engage Gen Z HCPs
Trust isn’t a campaign outcome; it’s the product of behaviour, language and consistency
Read More
Setting out – why omnichannel success is about orchestration
Today’s audiences listen simultaneously to multiple channels, from social media to digital detailing, which leak into each other like a commuter’s headphones on a crowded train
Read More
Global regulatory standards
The US, EU and UK operate under different systems, with distinct expectations for clinical evidence, timelines and commercial readiness
Read More
Patient insight: human vs AIHCPS
If we’re using AI to inform healthcare decisions, ethical guard rails are essential
Read More
Bridging the affordability gap
How pharma can rebuild competitiveness from the factory floor
Read More
ESMO 2025 – ensuring innovation isn’t lost in translation
This year marks the congress’s 50th anniversary, with the theme: Many journeys. One global community
Read More
Blogs
Latest
Where Are We Today With Artificial Intelligence (AI) in Rare Disease Diagnosis and Care?
December 23, 2025 | Medscape Education|
Discover how AI-powered tools are transforming rare disease diagnosis, patient care, and clinical decision-making.
Does Rare Disease Education Work?
December 23, 2025 | Medscape Education|
For a child with a rare disease, a doctor’s continuing education can end a years-long diagnostic odyssey and unlock access to vital care.
From Genetic Puzzles to Precision Therapeutics
December 23, 2025 | Medscape Education|
How was a new rare disease discovered through Singapore’s Undiagnosed Disease Program? And how will technology allow us to change how we discover rare diseases …
Medscape and the GNNRD: Empowering Nurses With a Rare Disease Education Series
December 23, 2025 | Medscape Education|
Nurses play a vital and multifaceted role in rare disease care, providing consistent patient support, education, and care coordination, and ongoing education is essential to …
What Is the RDI-Lancet Commission for Rare Disease and What Will It Achieve?
December 23, 2025 | Medscape Education|
Christy Rohani-Montez, Medscape’s Rare Disease Education Lead recently spoke with Dr Lucy McKay, CEO, and Megan Pullein, Strategic Operations Officer from the UK-based charity Medics …
What will healthcare communications look like in 2026? Amiculum’s prediction of upcoming trends
December 16, 2025 | Amiculum|AI, JCA, Market Access, Patient-integrated Communications, VuuAI, genAI, healthcare communications, misinformation, omnichannel, trends
By Sarah Theobald
Clinical research in 2026: The trends shaping tomorrow
December 16, 2025 | Cuttsy + Cuttsy|Communications, Decentralised trials, Digital, Pharma, advocacy, clinical trials, partnerships, patient engagement
Discover the key trends shaping clinical research in 2026, from patient-centric approaches to empowering site staff and fostering stronger human connections.
AI persona generation for healthcare: quick wins & real-world impact
December 4, 2025 | Amiculum|AI, Persona generation, Segmentation, artificial intelligence, healthcare communications, omnichannel
By Aaron Fletcher
From overwhelming to actionable: Bringing lifestyle guidance to life
December 2, 2025 | Cuttsy + Cuttsy|Inclusive design, communication, design, health literacy, patient engagement
Discover how clear communication and health literacy principles can transform complex patient materials into simple, engaging, and empowering health information.
Behind the scenes: why we created ‘The participation equation’
November 28, 2025 | Cuttsy + Cuttsy|Insights, Patient first, The participation equation, clinical trials, patient engagement
Go behind the scenes of The participation equation – our call to put people, not just data, at the heart of clinical research.